Methoden Alternative Promoter Verwendung und Transkriptions-Verordnung von Murine Bcrp1 zu entdecken
May 27th, 2016
•Karthika Natarajan1,2, Yi Xie1,3, Takeo Nakanishi4, Rebecca S. Moreci5,6, Pancharatnam Jeyasuria7, Arif Hussain1,3,8,9, Douglas D. Ross1,3,8,9,10,11
1Greenebaum Cancer Center, University of Maryland School of Medicine, 2Pharmaceutical Sciences, University of Maryland School of Pharmacy, 3Baltimore VA Medical Center, 4Membrane Transport and Biopharmaceutics, School of Pharmaceutical Sciences, Kanazawa University, 5Obstetrics, Gynecology and Reproductive Science, University of Pittsburgh, 6Magee Women's Research Institute, 7Obstetrics, Gynecology, Perinatal Research Branch (NICHD), Wayne State University School of Medicine, 8Medicine, University of Maryland School of Medicine, 9Pathology, University of Maryland School of Medicine, 10Pharmacology, University of Maryland School of Medicine, 11Experimental Therapeutics, University of Maryland School of Medicine
Mit dem murinen ABC transporter Bcrp1 (ABCG2) als Beispiel in-silico - Protokolle werden dargestellt , um alternative Promotor Gebrauch in Gene in Mausgeweben exprimiert erkennen und die Funktionalität der alternativen Promotoren unter Verwendung von Reporter - Assays identifiziert , zu bewerten.
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved